Hematology Updates
All the atest articles, research and news from worlds leading Haematology Journals. Discussion group https://t.me/Professional_Medical_Discussion
- 24 часа
- +3
- 7 дней
- –
- 30 дней
- +123
- Реакции
- 0
- Репосты
- –
- Комментарии
- –
Динамика подписчиков
Подписчиков у канала «Hematology Updates»: 7 092. Прирост за последние 30 дней: 123 (1,8 %).
По дням, последние 30 дней
| Дата | Подписчики | Изменение | Посты | Ср. просмотры поста |
|---|---|---|---|---|
| 11 ноя | 7 092 | +3 | 1 | 112 |
| 10 ноя | 7 089 | +6 | 0 | – |
| 9 ноя | 7 083 | 0 | 1 | 277 |
| 8 ноя | 7 083 | +4 | 0 | – |
| 6 ноя | 7 079 | +110 | 0 | – |
| 6 окт | 6 969 | – | 0 | – |
Просмотры по возрасту поста
Средние просмотры в каждом возрасте, посты за последние 30 дней.
- 7 дней
- 373
Когда публикует
Время по UTC. 22 поста за 90 дней.
Последние посты
-
Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML https://www.nature.com/articles/s41375-026-03173-0
112 просмотров -
Mesenchymal stromal cells drive immune escape in MDS and sAML through metabolic rewiring of NK cells https://www.nature.com/articles/s41375-026-03172-1
277 просмотров -
Hyperactivation of type I IFN signaling underlies a broad inflammatory program in VEXAS syndrome https://www.nature.com/articles/s41375-026-03186-9
469 просмотров -
Maternal donor risk in haploidentical transplant with post-transplant cyclophosphamide: the role of recipient sex https://www.nature.com/articles/s41375-026-03179-8
404 просмотров 2 Реакции -
Relcobatinib, a highly selective ATP-competitive ABL1 tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia https://www.nature.com/articles/s41375-026-03184-x
478 просмотров -
Salvage therapy for immune-mediated bone marrow failure https://www.nature.com/articles/s41375-026-03180-1
403 просмотров -
Mutant calreticulin-driven myeloproliferative neoplasms favour the emergence of TIGIT-positive NK cells https://www.nature.com/articles/s41375-026-03175-y
337 просмотров -
The cyclin-G associated kinase (GAK) is a clinically actionable drug target required for mitosis in diffuse large B-cell lymphoma https://www.nature.com/articles/s41375-026-03174-z
393 просмотров -
Clinical and molecular characteristics of <i>FLT3</i>-ITD microclones in elderly patients with acute myeloid leukemia receiving less-intensive therapy https://www.nature.com/articles/s41375-026-03165-0
490 просмотров -
[Articles] Incidence of clinically diagnosed infections in children with sickle cell anaemia treated with oral hydroxyurea in Angola, DR Congo, Kenya, and Uganda: a retrospective cohort study from the REACH trial https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00246-2/fulltext?rss=yes
445 просмотров
-
Clinical and molecular characteristics of <i>FLT3</i>-ITD microclones in elderly patients with acute myeloid leukemia receiving less-intensive therapy https://www.nature.com/articles/s41375-026-03165-0
490 просмотров -
Relcobatinib, a highly selective ATP-competitive ABL1 tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia https://www.nature.com/articles/s41375-026-03184-x
478 просмотров -
Hyperactivation of type I IFN signaling underlies a broad inflammatory program in VEXAS syndrome https://www.nature.com/articles/s41375-026-03186-9
469 просмотров -
[Articles] Incidence of clinically diagnosed infections in children with sickle cell anaemia treated with oral hydroxyurea in Angola, DR Congo, Kenya, and Uganda: a retrospective cohort study from the REACH trial https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00246-2/fulltext?rss=yes
445 просмотров -
Maternal donor risk in haploidentical transplant with post-transplant cyclophosphamide: the role of recipient sex https://www.nature.com/articles/s41375-026-03179-8
404 просмотров 2 Реакции -
Salvage therapy for immune-mediated bone marrow failure https://www.nature.com/articles/s41375-026-03180-1
403 просмотров -
[Comment] Hydroxyurea benefits for sickle cell anaemia in sub-Saharan Africa https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00261-9/fulltext?rss=yes
402 просмотров -
The cyclin-G associated kinase (GAK) is a clinically actionable drug target required for mitosis in diffuse large B-cell lymphoma https://www.nature.com/articles/s41375-026-03174-z
393 просмотров -
[Articles] MK-4002, a B-cell maturation antigen-targeting T-cell engager, in relapsed or refractory multiple myeloma: a first-in-human, open-label, phase 1 study https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00228-0/fulltext?rss=yes
339 просмотров -
Mutant calreticulin-driven myeloproliferative neoplasms favour the emergence of TIGIT-positive NK cells https://www.nature.com/articles/s41375-026-03175-y
337 просмотров
Вопросы о канале «Hematology Updates»
Сколько подписчиков у канала «Hematology Updates»?
У канала «Hematology Updates» (@haematology_updates) 7 092 подписчика на 12 ноября 2026 г.
Растёт ли канал «Hematology Updates»?
Да. Прирост за последние 30 дней: 123 (1,8 %).
О чём канал «Hematology Updates»?
Канал в категории «Здоровье», язык постов: английский. Описание канала: «All the atest articles, research and news from worlds leading Haematology Journals. Discussion group https://t.me/Professional_Medical_Discussion»
Какое место занимает канал «Hematology Updates»?
По числу подписчиков: №146 в категории «Здоровье», №2 610 среди каналов на языке «английский», №3 058 в мире.
Публикует ли канал «Hematology Updates» рекламу?
За последние 30 дней ни один из 22 постов не помечен как реклама (#ad, Sponsored, «Реклама»). Рекламу без пометки определить нельзя.
Когда публикует канал «Hematology Updates»?
Пик публикаций: пятница, около 01:00 по UTC. Выходит около 2 постов в день.
Статистика обновлена 19 минут назад.